Anal cancer, Secondary cancers
Results
Phase 3
This trial looked at adding retifanlimab to chemotherapy to improve treatment for anal cancer.
It was for people having chemotherapy for the first time and whose cancer:
had come back or
had spread elsewhere in the body
You pronounce retifanlimab as reh-tih-fan-lih-mab.
People could join the trial between 2020 and 2023. The team published the results in 2025.
Recruitment start: 12 November 2020
Recruitment end: 3 July 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sheela Rao
Incyte Corporation
Last reviewed: 01 Jul 2026
CRUK internal database number: 17943
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
